irritable bowel syndrome
Elimination Diets Call for Caution and Adaptation
Elimination diets have the potential to benefit patients with GI diseases, but can be difficult to adhere to and ...
AUGUST 26, 2025
FDA Approves the Reintroduction of Zelnorm for IBS-C in Certain Women
After being pulled from the market over safety concerns more than 15 years ago, tegaserod is being reintroduced for ...
APRIL 2, 2019
FDA Warns Against Use of Viberzi for Patients Without Gallbladder
The FDA reported that eluxadoline (Viberzi, Allergan) has been linked to severe pancreatitis and death in patients ...
MARCH 16, 2017
Load more